Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 51 % of short-term debt in 2024; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
Medicorps-Invest from Antwerpen, company number BE0757843479, closed financial year 2024 with a result of € -1,196 after tax. For that financial year Medicorps-Invest recorded a gross margin of € -780 and equity of € 23,415. Compared with financial year 2023, the result moved from € -389 to € -1,196. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 24, 2026.
€ 23,415
▼ 5% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,196
▼ 208 % more loss than in 2023
Profit after tax over the fiscal year.
€ 1,815
▼ 23% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1,585.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | - | € -389 | € -780 | ▼ € 391 |
| Profit after taxes | € 0 | € -389 | € -1,196 | ▼ € 807 |
| Equity | € 25,000 | € 24,611 | € 23,415 | ▼ 5% |
| Total debts | € 285,000 | € 431,689 | € 532,300 | ▲ 23% |
| Cash | € 25,000 | € 2,364 | € 1,815 | ▼ 23% |
| Retained profit | € 0 | € -389 | € -1,585 | ▼ € 1,196 |
| Balance sheet total | € 310,000 | € 456,300 | € 555,715 | ▲ 22% |
Key figures of Medicorps-Invest, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Medicorps-Invest?
What happened at Medicorps-Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2023: loss of € 389. filed late Source: NBB ↗
- New establishment in Malle. KBO
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2022 to € 1,196 loss in 2024.
A new publication or filing at Medicorps-Invest? We notify you, reason included.
Follow Medicorps-InvestDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Baan-Chang comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Medicorps-InvestBehind Medicorps-Invest are Limasol BV, Edmond D'hont, Ficlasol BV and Ficaz BV. The shares are held by Baan-Chang (50%).
Directors
According to the 2024 annual accounts
Edmond D'hont
Director
Director · represented by Armand Gilissen
Also active at: SKINCENTERS ANTWERPEN, MEDI - INVEST, Zimmer Benelux, Skincenters Brussel, Skincenters Mechelen, Skincenters Malle, ENRAF-NONIUS BELUX
Director · represented by Matthias Stas
Also active at: SKINCENTERS ANTWERPEN, Zimmer Benelux, Skincenters Brussel, Skincenters Mechelen, Skincenters Malle, ENRAF-NONIUS BELUX
Shareholders
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Boekenberglei 114
2100 Antwerpen
Zwaluwenlaan 2
2390 Malle
Active since 5 November 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Rackspace Email
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0757.843.479
- VAT number
- BE 0757.843.479
- Registered office
- Boekenberglei 114, 2100 Antwerpen
- Names & denominations
- Medicorps-Invest
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 November 2020
- Peppol
- Not registered
- Contact
- skinline.be +32491418786